These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7252332)

  • 41. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production.
    Tavares-Murta BM; Cunha FQ; Ferreira SH
    Br J Pharmacol; 1998 Aug; 124(7):1369-74. PubMed ID: 9723947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory dysfunction in leukotaxis.
    Ward PA; Johnson KJ; Kreutzer DL
    Am J Pathol; 1977 Sep; 88(3):701-10. PubMed ID: 142429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct chemokinetic and chemotactic responses in neutrophil granulocytes.
    Keller HU; Wissler JH; Hess MW; Cottier H
    Eur J Immunol; 1978 Jan; 8(1):1-7. PubMed ID: 639837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy.
    Mendonça MA; Cunha FQ; Murta EF; Tavares-Murta BM
    Cancer Chemother Pharmacol; 2006 May; 57(5):663-70. PubMed ID: 16133528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases.
    Montecucco F; Bianchi G; Gnerre P; Bertolotto M; Dallegri F; Ottonello L
    Ann N Y Acad Sci; 2006 Jun; 1069():463-71. PubMed ID: 16855174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of MIP-1alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites.
    Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA
    J Lab Clin Med; 2000 Feb; 135(2):161-9. PubMed ID: 10695661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary epithelial cells facilitate TNF-alpha-induced neutrophil chemotaxis. A role for cytokine networking.
    Smart SJ; Casale TB
    J Immunol; 1994 Apr; 152(8):4087-94. PubMed ID: 8144974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
    Johnson KJ; Anderson TP; Ward PA
    J Clin Invest; 1977 May; 59(5):951-8. PubMed ID: 140184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxyapatite associated arthritis in a patient undergoing chronic haemodialysis.
    Yano E; Takeuchi A; Yoshioka M
    Int J Tissue React; 1985; 7(6):527-34. PubMed ID: 4086222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
    Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
    J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).
    Goetzl EJ; Pickett WC
    J Immunol; 1980 Oct; 125(4):1789-91. PubMed ID: 7410854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum.
    Mackerness KJ; Jenkins GR; Bush A; Jose PJ
    Thorax; 2008 Jul; 63(7):614-20. PubMed ID: 18245144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I.
    Ottonello L; Ghio M; Contini P; Bertolotto M; Bianchi G; Montecucco F; Colonna M; Mazzei C; Dallegri F; Indiveri F
    Transfusion; 2007 Aug; 47(8):1395-404. PubMed ID: 17655583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclocreatine inhibits neutrophil accumulation in the myocardium of a canine model of coronary artery occlusion and reperfusion.
    Elgebaly SA; Allam ME; Houser S; Hashmi F; Forouhar F; Miano D
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1670-7. PubMed ID: 8371165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two distinct chemotactic factor inactivators in human serum.
    Till G; Ward PA
    J Immunol; 1975 Feb; 114(2 pt 2):843-7. PubMed ID: 46254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effect of heparin on leucocyte chemotactic factors.
    Czarnetzki BM; Panneck W; Frosch PJ
    Clin Exp Immunol; 1980 Feb; 39(2):526-31. PubMed ID: 6771079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.